SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020607
Filing Date
2024-02-27
Accepted
2024-02-27 06:42:43
Documents
66
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nuvl-20231231.htm   iXBRL 10-K 2455733
2 EX-10.2 nuvl-ex10_2.htm EX-10.2 35699
3 EX-23.1 nuvl-ex23_1.htm EX-23.1 3205
4 EX-31.1 nuvl-ex31_1.htm EX-31.1 10280
5 EX-31.2 nuvl-ex31_2.htm EX-31.2 10494
6 EX-32.1 nuvl-ex32_1.htm EX-32.1 5301
7 EX-32.2 nuvl-ex32_2.htm EX-32.2 5573
8 EX-97.1 nuvl-ex97_1.htm EX-97.1 25822
9 GRAPHIC img239658702_0.jpg GRAPHIC 542366
10 GRAPHIC img239658702_1.jpg GRAPHIC 687159
  Complete submission text file 0000950170-24-020607.txt   10916374

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvl-20231231.xsd EX-101.SCH 1088691
67 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20231231_htm.xml XML 1108141
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40671 | Film No.: 24681860
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)